Day: May 29, 2025

Next-Gen Infrastructure Integrates AI, Encryption, and Blockchain to Power the Future of Data Sovereignty and Institutional Monetization KUALA LUMPUR, Malaysia, May 29, 2025 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”), a diversified global holding company, today announced the stealth development of Project QG, a next-generation infrastructure platform designed to enable sovereign AI deployment and unlock a new era of encrypted data monetization for governments and institutions. Now entering the proof-of-concept stage, Project QG fuses AI-driven hardware encryption, zero-trust computing, and blockchain validation to deliver what VCI Global believes could become a foundational layer for the future of AI and data sovereignty. Redefining Data Control and Value Creation in the AI Era A vast majority...

SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) — Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with renal, metabolic and cardiovascular diseases, today announced that Jason Coloma, Ph.D., chief executive officer of Maze Therapeutics, will present a company overview at the Jefferies 2025 Global Healthcare Conference on Thursday, June 5, 2025 at 2 p.m. ET. A live webcast will be available in the Investors section of the company’s website at www.MazeTx.com and archived for 60 days following the presentation. About Maze TherapeuticsMaze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular...

SAN FRANCISCO and BOSTON, May 29, 2025 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 10:30 a.m. E.T. A live and archived webcast of the fireside chat will be available via the News & Events page in the Investors section of the Apogee Therapeutics website. About Apogee Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, including for the treatment of AD, asthma, EoE, COPD and other I&I indications. Apogee’s antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action...

All-Natural Line of Wellness Products Designed to Support Overall Well-Being Now Available in Massachusetts NORWOOD, Mass., May 29, 2025 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), the company behind the award-winning flower and concentrate brand, Nature’s Heritage™, continued to drive innovation with the launch of MycroDose by Nature’s Heritage, a vegan line of all-natural wellness products that combine the power of full-spectrum cannabis with the added benefits of functional mushrooms in a convenient pill form. MycroDose by Nature’s Heritage delivers four targeted, plant-based solutions designed to enhance mental clarity, promote relaxation, improve focus, and support overall well-being in four distinct formulations. They are available now in Massachusetts at MariMed’s own Panacea Wellness stores...

TORONTO, May 29, 2025 (GLOBE NEWSWIRE) — Dividend 15 Split Corp. (the “Company”) announced today that the Toronto Stock Exchange (the “TSX”) has accepted its notice of intention to make a Normal Course Issuer Bid (the “NCIB”) to purchase its Preferred Shares and Class A Shares through the facilities of the TSX and/or alternative Canadian trading systems. The NCIB will commence on June 2, 2025 and terminate on June 1, 2026. Pursuant to the NCIB, the Company proposes to purchase, from time to time, if it is considered advisable, up to 12,687,975 Preferred Shares and 13,219,443 Class A Shares of the Company, representing 10% of the public float of 126,879,752 Preferred Shares and 132,194,435 Class A Shares. As of May 21, 2025, there were 127,069,383 Preferred Shares and 132,275,624 Class A Shares issued and outstanding. The Company...

TORONTO, May 29, 2025 (GLOBE NEWSWIRE) — Financial 15 Split Corp. (the “Company”) announced today that the Toronto Stock Exchange (the “TSX”) has accepted its notice of intention to make a Normal Course Issuer Bid (the “NCIB”) to purchase its Preferred Shares and Class A Shares through the facilities of the TSX and/or alternative Canadian trading systems. The NCIB will commence on June 2, 2025 and terminate on June 1, 2026. Pursuant to the NCIB, the Company proposes to purchase, from time to time, if it is considered advisable, up to 6,054,449 Preferred Shares and 6,196,492 Class A Shares of the Company, representing 10% of the public float of 60,544,490 Preferred Shares and 61,964,925 Class A Shares. As of May 21, 2025, there were 60,567,417 Preferred Shares and 61,968,317 Class A Shares issued and outstanding. The Company will...

TORONTO, May 29, 2025 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV:FW) (“Flow Capital” or the “Company”) is pleased to announce the successful closing of a US$5.0 million senior note investment in Congruity 360, a leading provider of unstructured data management and risk mitigation solutions. Congruity 360’s Classify360 platform equips organizations with critical capabilities to understand, manage, and secure petabyte-scale unstructured data across cloud, SaaS, and on-premises environments. Its capabilities include data discovery and classification, identification of governance and compliance vulnerabilities, and automated workflows for remediation and infrastructure optimization. Already trusted by Fortune 500 companies operating across the globe, Congruity 360 will use the capital to fuel continued product innovation and growth. “The...

VANCOUVER, British Columbia, May 29, 2025 (GLOBE NEWSWIRE) — Coppernico Metals Inc. (TSX: COPR, OTCQB: CPPMF) (“Coppernico” or the “Company”), is pleased to announce the details of its upcoming virtual Annual General Meeting of Shareholders (the “Meeting”), to be held on Tuesday, June 24, 2025, at 10:00 a.m. Pacific Time, as well as a leadership fireside chat hosted by 3L Capital (the “Webinar”), scheduled for Wednesday, June 4, 2025, at 8:00 a.m. Pacific Time. Annual General Meeting of Shareholders The Meeting will be held in a virtual-only format via live webcast. Access details are provided below. Annual General Meeting DetailsDate: Tuesday, June 24, 2025Time: 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time)Webcast Link: https://meetnow.global/M4F4ATS The record date for determining the shareholders entitled...